A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

Abstract

A population survey of 258 unrelated white British subjects showed a polymorphism for the 4-oxidation of debrisoquine. "Extensive metabolisers" (EM) and "poor metabolisers" (PM) are recognisable, 8.9% of the population being PM. Nine pedigrees ascertained through PM probands show that the PM phenotype is an autosomal Mendelian recessive character. The EM phenotype is dominant and the degree of dominance has been estimated at 30%. PM subjects are more prone to hypotension during debrisoquine therapy. The alleles controlling this polymorphism appear to control the oxidation of other drugs.

Statistics

050010001500'82'85'89'93'97'01'05'09'13'17
Citations per Year

14,886 Citations

Semantic Scholar estimates that this publication has 14,886 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Evans1980AFA, title={A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.}, author={D A Evans and A Mahgoub and T P Sloan and J R Idle and R L Smith}, journal={Journal of medical genetics}, year={1980}, volume={17 2}, pages={102-5} }